Edition:
United Kingdom

Eiger BioPharmaceuticals Inc (EIGR.OQ)

EIGR.OQ on NASDAQ Stock Exchange Global Market

11.20USD
4:12pm GMT
Change (% chg)

$-0.02 (-0.18%)
Prev Close
$11.22
Open
$11.25
Day's High
$11.31
Day's Low
$11.10
Volume
10,300
Avg. Vol
31,421
52-wk High
$18.00
52-wk Low
$7.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.78 December 11 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 5 5
(2) OUTPERFORM 1 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.17 1.29 1.29 1.29

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 4 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 4 0.00 0.00 0.00 3.33
Year Ending Dec-19 5 2.49 12.47 0.00 7.83
Earnings (per share)
Quarter Ending Dec-18 5 -0.78 -0.71 -0.86 -1.20
Quarter Ending Mar-19 3 -0.74 -0.67 -0.82 -1.27
Year Ending Dec-18 5 -3.55 -3.21 -3.74 -4.54
Year Ending Dec-19 4 -3.13 -2.86 -3.36 -4.68

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 0.00 0.00 0.00 0.00
Quarter Ending Jun-18 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 0.00 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 0.00 0.00 0.00 0.00 3.33
Year Ending Dec-19 2.49 2.49 8.92 8.92 7.83

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 1
Earnings